Brand

Endo rebrands to move beyond roots in pain drugs

March 02, 2012

Endo is restructuring, bringing its four operating units under the same corporate roof and rebranding to reflect its diversification out of its origins in pain and urology drugs.
 

FDA gives guidance on brand, generic names in ads

January 26, 2012

The FDA issued guidance clarifying narrow questions of scientific or generic name placement in ads and labeling in different media, including electronic media.
 

As GSK jettisons consumer brands, smaller marketer sees boon

December 28, 2011

GlaxoSmithKline divested North American OTC drugs worth about $200 million in sales, a portfolio that seemed like a good strategic fit for buyer Prestige Brands Holdings.
 

As brand revenue shrinks, so does brand promotion

April 22, 2011

Branded drug sales declined 0.7% to $229 billion last year, according to IMS Health, and that's having an impact on promotional spend.
 

Viagra, Nexium and Chantix are Mensa-worthy brands, says digital IQ study

May 06, 2010

Marketers working on Pfizer brands Viagra and Chantix, and AstraZeneca's Nexium, can pat themselves on the back, since they all scored in the "genius" percentile based on digital marketing competency, according to the L2 Digital IQ Index.
 

E-samples hijack search, study asserts

December 02, 2009

Many big pharma firms are running e-samples, a form of marketing which researchers say capitalizes on patients seeking health information and may affect prescribers' preference for brands over generics.
 

UCB turns Crohn's patients into brand advocates

September 30, 2009

UCB launched a multifaceted campaign for its Cimzia injectable, calling on patients and doctors to publicly educate others about Crohn's disease and treatment.
 

Last chance to grab glory

June 04, 2009

If you still haven't entered the MM&M Awards 2009, then you'd better move fast--today (June 5) is the final deadline for submissions.
 

Abbott, AZ extend co-promotion to Trilipix

June 04, 2009

AstraZeneca will help Abbott reach more physicians with its Trilipix (fenofibric acid) drug, a cholesterol product approved by FDA last December. The companies also filed an NDA for Certriad, a Trilipix/Crestor combination drug.
 

Gelnique ads swap embarrassment for empowerment

May 21, 2009

Watson launched a campaign today for its overactive bladder product Gelnique - the first topical gel indicated for the disorder - featuring younger, active women.
 

Worldwide, consumers prefer generics, says study

April 22, 2009

Consumers worldwide overwhelmingly prefer medicines that have been around a long time to the latest treatments, and over half prefer generics to branded drugs given the choice, according to a DDB Health survey.
 

GSK pairs Wynonna Judd album with Alli

March 16, 2009

Consumers purchasing GSK's weight loss drug Alli will receive a free copy of Wynonna Judd's new album "Sing," beginning in March.
 

McCann launches experiential marketing shop

February 05, 2009

McCann Worldgroup is launching a health and wellness experiential marketing practice under the umbrella of its Momentum network.
 

Lantus site tops in consumer satisfaction: study

February 03, 2009

The product site for Sanofi-Aventis's insulin injection Lantus received the highest mark in terms of consumer satisfaction, according to a Manhattan Research study.
 

Pfizer taps McGarryBowen on Chantix, snubs McCann

February 02, 2009

Pfizer passed Chantix creative work to McGarryBowen, ending McCann HumanCare's contract on the smoking cessation drug, agency sources confirmed.
 

Lilly enters CIA as part of $1.4 billion settlement

January 15, 2009

As part of its $1.415 billion settlement for off-label marketing of Zyprexa, Eli Lilly & Co. will enter a Corporate Integrity Agreement with the HHS Office of Inspector General.
 

TBWA wins three global Merck brands

September 03, 2008

Merck KGaA has tapped TBWA on three of its consumer healthcare brands: Nasivin, Femibion and Flexagil.
 

New Lipitor ad features testimonial from heart attack survivor

September 02, 2008

Pfizer resumes DTC advertising for Lipitor, without Robert Jarvik.
 

Manhattan Research names top product sites for docs

August 25, 2008

A new study identifies the top 10 product sites visited by primary care physicians.
 

Vioxx trial described as marketing stunt

August 20, 2008

Researches involved in the litigation against Vioxx claim the product's ADVANTAGE trials were based on marketing objectives rather than scientific rigor.
 

Advair superior to Singulair for asthma and allergies: study

May 20, 2008

Advair outperformed Singulair in patients suffering from asthma and seasonal allergies, according to a study conducted by the National Jewish Medical Research Center.
 

Sudler & Hennessey named global AOR for developmental arthritis med

March 21, 2008

Sudler & Hennessey (S&H) has been selected by AstraZeneca as the global agency partner of record for the developmental arthritis treatment PN400.
 

Crestor ads take aim at Vytorin, touting atherosclerosis claim

March 11, 2008

AstraZeneca is going for the jugular - or rather, the carotid - with new ads emphasizing Crestor's effectiveness at slowing the progression of atherosclerosis.
 

Blueprint for Branding Devices

David Paragamian March 01, 2008

David Paragamian emphasizes the importance of building master brands and exploring promotional channels
 

Nexium could face early generic challenge, say analysts

February 26, 2008

AstraZeneca's Nexium could face generic competition much sooner than expected, and would-be investors should be wary, said brokerage firm Sanford C. Bernstein in an analyst note.
 

Drug wholesale prices up over 7% in 2007

February 21, 2008

Pharmaceutical manufacturers increased wholesale prices for the 50 top-selling branded medications by an average of 7.82% in 2007, after increases of 6.73% and 6.22% in the previous two years, according to data from marketing research firm Delta Marketing Dynamics.
 

Australian regulators issue warning on Novartis' Lamisil

February 05, 2008

Australia's drug and medical device regulatory agency, the Therapeutic Goods Administration (TGA), has issued a warning concerning nail fungus treatment Lamisil (terbinafine) tablets following reports of three deaths and severe liver reactions among patients.
 

NitroMed to axe BiDil reps

January 16, 2008

NitroMed announced it plans to lay off a majority of its newly hired BiDil sales force by roughly 70 to 90 employees.
 

GSK to shift consumer media business by end of Feb.

December 21, 2007

GlaxoSmithKline should be finished transitioning the media planning and buying for its North American OTC business by the end of February, a spokesperson for the drugmaker said.
 

MM&M launches New Drug Dossier

November 30, 2007

MM&M's New Drug Dossier is designed to give pharmaceutical marketers authoritative promotional and clinical insights on the latest new molecular entities in one online resource.
 

Video Exclusive

Web Exclusives

Five industry experts advise specialty pharma company on digital strategy

April 20, 2012

Specialty pharma company POZEN assembled a crack team of experts to help shape its digital strategy. Not only did POZEN share with us the text from their contributions, but you can watch exclusive video clips of their valuable perspectives right here.
 

MM&M Awards 2011 HIghlights

The Best MM&M Awards Ever!

MAHF Ceremony 2012

Photos from the Medical Advertising Hall of Fame Awards ceremony
 
Popular Topics
Acquisition Adherence App Celebrity Clinical Trial Co-Marketing Conflict Of Interest Diabetes Diagnostics Digital Direct To Consumer (DTC) Disease Awareness Downsize Education & Awareness FDA Government Guidance Health Plans HMOs Hospitals Insurers Law Marketing Research Mobile Sales Force